Agenus | AGEN - Ativo Circulante

Preço das Ações
4.13
Mudança Diária
-0.04 -0.96%
Mensal
9.55%
Anual
39.06%
Q2 Previsão
3.76




Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Agenus USD 133.44M 514K 2025-12
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Celldex Therapeutics USD 534.66M 69.68M 2025-12
CSL USD 11.85B 1000K 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 59.17B 3.55B 2026-03
Jiangsu Hengrui CNY 52.04B 553.82M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Merck EUR 13.23B 354M 2025-12
Merck USD 35.02B 8.5B 2026-03
Northwest Biotherapeutics USD 7.2M 1.04M 2025-09
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 522.17M 33.8M 2026-03